Contec Medical Systems Co Ltd - Asset Resilience Ratio
Contec Medical Systems Co Ltd (300869) has an Asset Resilience Ratio of 22.69% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 300869 total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how Contec Medical Systems Co Ltd's Asset Resilience Ratio has changed over time. See Contec Medical Systems Co Ltd shareholders equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Contec Medical Systems Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300869 stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥633.33 Million | 22.69% |
| Total Liquid Assets | CN¥633.33 Million | 22.69% |
Asset Resilience Insights
- Good Liquidity Position: Contec Medical Systems Co Ltd maintains a healthy 22.69% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Contec Medical Systems Co Ltd Industry Peers by Asset Resilience Ratio
Compare Contec Medical Systems Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for Contec Medical Systems Co Ltd (2021–2024)
The table below shows the annual Asset Resilience Ratio data for Contec Medical Systems Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 6.30% | CN¥171.59 Million ≈ $25.11 Million |
CN¥2.73 Billion ≈ $398.83 Million |
-14.00pp |
| 2023-12-31 | 20.30% | CN¥652.02 Million ≈ $95.41 Million |
CN¥3.21 Billion ≈ $470.01 Million |
+19.05pp |
| 2022-12-31 | 1.25% | CN¥46.64 Million ≈ $6.82 Million |
CN¥3.73 Billion ≈ $546.23 Million |
-5.56pp |
| 2021-12-31 | 6.81% | CN¥189.98 Million ≈ $27.80 Million |
CN¥2.79 Billion ≈ $408.12 Million |
-- |
About Contec Medical Systems Co Ltd
Contec Medical Systems Co.,Ltd engages in the research and development, production, and sale of medical diagnosis and monitoring equipment in China and internationally. The company offers electronic sphygmomanometers, ambulatory blood pressure monitors, pulse oximeters, patient monitors, stethoscopes, simulators, multi-parameter vital signs monitors, central monitoring systems, electrocardiograph… Read more